References
- Speat TH. Progress in hemostasis and thrombosis. USA: Grune & Stration; 1972. p 75–92.
- Sohoppmann A, Waytes AT. Factor VIII inhibitor and severity of hemophilia. Thromb Hemost 1996;76 (2):275–281.
- Mollison PL, Engelfreit CP, Cotreras M. Blood transfusion in clinical medicine. 10th ed. USA: Blackwell Science; 1998. p 476–480.
- Oldenberg J, Brackmann HH, Sch-waab R. Risk factor inhibitor development in hemophilia. Haematologica 2000; 85(10):8.
- Kasper CK, Aledort LM, Counts RB, Biggs R, Rizza C. A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorr 1975;34:870.
- Klinge J, Auerswald G, Budde U, Kl-ose H, Kreuz W, Gringeri A, Miraglia S, et al. Detection of all factor VIII antibodies in hemophilia A patients by bethesda assay and a more sensitive immunoprecipitation assay. Hemophilia 2002;8:29.
- Lossing ST, Kasper CK, Feinstein DI, Counts RB. Detection of factor VIII Inhibitor with the partial prothrombin time. Blood 1997;49(7):741.
- Chanarin I, Gawley JC, Contreras M, Knight RC, Machin SJ. Laboratory hematology, an account of laboratory techniques. 1st ed. USA: Churchill livingston; 1989. p 375.
- Ehernforth S, Kreuz W, Scharrer I, li-nde R, Funk M, Gian P, et al. Incidence of development of factor VIII and factor IX inhibitors in hemophilics. Lancet 1992;:339–596.
- Rothachild C, laurian Y, Stary EP, Borel A, Chanbost H, Carel D, et al. French previously untreated patients with severe hemophilia A after exposure to recombinant factor VIII: Incidence of inhibitor and evaluation of immune tolerance. Thromb Haemost 1998;80:779.
- Rasi V, Ikkala E. Haemophilia with factor VIII inhibitors in Finland; prevalence, incidence and outcome. BJH 1990;79:36.
- Jeame M. Inhibitor in young boys with hemophilia. Res Chin Hematol 2000;13(3) :457.
- Bernard Henry, Davidson J. Clinical diagnosis and manage-ment by laboratory methods. 9th ed. USA: WB Saunders; 1996. p 1402.
- Tadashi K, Takahashi I, Hidchiko S, Saito H. Retrospective study of inhibitor formation in Japanese hemophilia. Inter J Hematol 1995;62:175.
- Colvin BT, Hay CRM, Preston FE, Hill FGH. Incidence of factor VIII inhibitor in the United Kingdom. BJH 1995;89:909.
- Rosendeal FR, Nieu wenhuis HR, Vandenberg H, Heijboer H, Mauster EP, Edvil M, et al. A sudden increase in factor VIII inhibitor development in multitransfused hemophilia A patient in The Netherland. Blood 1993;81(8):2180.